What legal options are available to Pradaxa patients and their loved ones?
Patients who suffered serious bleeding events while taking Pradaxa, as well as loved ones acting on their behalf may be able to file a claim against the manufacturer for compensation. To learn more about your eligibility for legal recourse, contact us today for a free case review.
Does Pradaxa increase the risk of gastrointestinal bleeding?
Several studies have shown that Pradaxa puts patients at an increased risk for gastrointestinal (GI) bleeding than the traditional anticoagulants, including the initial trial that helped get Pradaxa approved by the FDA. One study published found users of Pradaxa were more than 1.5-times more likely to suffer from gastrointestinal bleeding than users or warfarin. The study also found patients taking Pradaxa were 1.3-times more likely to suffer from any sort of bleeding episode compared to patients taking warfarin.
Are there lawsuits against the makers of Pradaxa?
There is pending litigation against the makers of Pradaxa in U.S. federal court. The lawsuits allege the company failed to adequately warn consumers about the potential risks of the drug. Thousands of lawsuits were consolidated in a multi-district litigation (MDL) in the U.S. District Court for the Southern District of Illinois. Currently, four are pending in the MDL overseen by U.S. District Judge David R. Herndon. In 2014, Boehringer-Ingelheim announced it would settle roughly 4,000 cases pending in federal court for $650 million. The company did not admit wrongdoing even though it agreed to a settlement.